Your session is about to expire
← Back to Search
Brachytherapy
Experimental: Intra-operative Radiation Therapy - IORT for Breast Cancer
N/A
Waitlist Available
Led By A. M. Nisar Syed, MD
Research Sponsored by Xoft, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up reported at 5 years
Awards & highlights
Study Summary
This trial is testing whether a new type of radiation therapy, called IORT, is better than the current standard of care, whole breast irradiation (WBI), for women with early stage breast cancer.
Eligible Conditions
- Breast Cancer
- Ductal Carcinoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ reported at 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~reported at 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assess the rate of ipsilateral breast tumor recurrence (IBTR) at 5 years
Trial Design
1Treatment groups
Experimental Treatment
Group I: Experimental: Intra-operative Radiation Therapy - IORTExperimental Treatment1 Intervention
Intra-operative Radiation Therapy
Find a Location
Who is running the clinical trial?
Xoft, Inc.Lead Sponsor
10 Previous Clinical Trials
2,487 Total Patients Enrolled
3 Trials studying Breast Cancer
182 Patients Enrolled for Breast Cancer
Icad, Inc.Industry Sponsor
4 Previous Clinical Trials
1,348 Total Patients Enrolled
A. M. Nisar Syed, MDPrincipal InvestigatorLong Beach Memorial Medical Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger